Pooled Analysis of Tanezumab Efficacy and Safety with Subgroup Analyses of Phase III Clinical Trials in Patients with Osteoarthritis Pain of the Knee or Hip [Corrigendum]

Abstract

Tive L, Bello AE, Radin D, et al. J Pain Res. 2019;12:975 —995. The authors have advised there is an error in the middle panels of Figure 6 on page 985. Both panels read “Patients with severe OA” the panel on the right should read “Patients with less severe OA”. The correct Figure 6 is shown below. Read the original article

Keywords

• tanezumab
• efficacy
• safety
• osteoarthritis
• nerve growth factor